Mass spectrometry analysis revealed distinct reaction pathways of d(CpoxG) with a photoactivatable Pt(IV) anticancer prodrug

Abstract

The interactions between d(CpoxG) (oxG = 8-oxo-guanine), a major form of oxidative damaged motif of CpG island, and a photoactivatable anticancer Pt(IV) prodrug, trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2] (1) was investigated by electrospray ionization mass spectrometry (ESI-MS). Surprisingly, the primary MS analysis showed the major photooxidative products being platinum-free dinucleotides, d(CpGh) (2a)/d(CpIa) (2b) (possibly a mixture of the two isomers) and d(CpDGh) (3), of which the guanine was oxidized to guanidinohydantoin (Gh) or iminoallantoin (Ia), and hydroguanidinohydantoin (DGh), respectively. Moreover, two mono-platinated adducts, {[CpGh] + 1′}+ (4) and {[CpDGh] + 1′}+ (5) (1′ = [PtII(N3)(py)2]2+), and three Pt-crosslinked dinucleotide adducts, {[CpDGh]2 + 1″}2+ (6), {[CpGh] + [CpDGh] + 1″}2+ (7) and {[CpGh]2 + 1″}2+ (8) (1″ = [PtII(py)2]2+), were observed as main platinated adducts. Tandem mass spectrometry with collision induced dissociation (CID) demonstrated that 1′ bound at Gh or DGh in 4 and 5, while the inter-dinucleotide crosslinks by 1″ between DGhs, DGh and Gh, or Ghs in 6, 7 and 8 were implicated. Unexpectedly, the supposed platinated d(CpoxG) adducts were not observed, indicating that oxG is preferential to be further oxidated by the reactive oxygen species released during the photodecomposition of complex 1 rather than to coordination with the reduced Pt(II). These results revealed a more complexity of photo-interaction of complex 1 with d(CpoxG) than with d(CpG), implicating that oxG-containing DNA, in particular oxidative CpG island, might play a vital role in the action of mechanism of photoactivatable Pt(IV) prodrugs, deserving further exploration.

Supplementary files

Article information

Article type
Paper
Submitted
12 Jul 2025
Accepted
30 Aug 2025
First published
01 Sep 2025

Analyst, 2025, Accepted Manuscript

Mass spectrometry analysis revealed distinct reaction pathways of d(CpoxG) with a photoactivatable Pt(IV) anticancer prodrug

J. Zhang, Z. Ma, J. Lin, W. Li, X. Wu, Y. Zhao, F. Wang and K. Wu, Analyst, 2025, Accepted Manuscript , DOI: 10.1039/D5AN00728C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements